NO993670D0 - Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as a drug for the treatment of AIDS - Google Patents

Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as a drug for the treatment of AIDS

Info

Publication number
NO993670D0
NO993670D0 NO993670A NO993670A NO993670D0 NO 993670 D0 NO993670 D0 NO 993670D0 NO 993670 A NO993670 A NO 993670A NO 993670 A NO993670 A NO 993670A NO 993670 D0 NO993670 D0 NO 993670D0
Authority
NO
Norway
Prior art keywords
quinoxaline
aids
inhibitors
drug
treatment
Prior art date
Application number
NO993670A
Other languages
Norwegian (no)
Other versions
NO993670L (en
Inventor
Arnold Paessens
Martin Blunck
Guenter Riess
Joerg-Peter Kleim
Manfred Roesner
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO993670D0 publication Critical patent/NO993670D0/en
Publication of NO993670L publication Critical patent/NO993670L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO993670A 1997-01-29 1999-07-28 Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as drugs for the treatment of AIDS NO993670L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19703131A DE19703131A1 (en) 1997-01-29 1997-01-29 Use of quinoxaline in a combination of three with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of AIDS and / or HIV infections
PCT/EP1998/000197 WO1998032442A1 (en) 1997-01-29 1998-01-15 Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids

Publications (2)

Publication Number Publication Date
NO993670D0 true NO993670D0 (en) 1999-07-28
NO993670L NO993670L (en) 1999-09-10

Family

ID=7818634

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993670A NO993670L (en) 1997-01-29 1999-07-28 Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as drugs for the treatment of AIDS

Country Status (16)

Country Link
EP (1) EP0977570A1 (en)
JP (1) JP2001511124A (en)
KR (1) KR20000070543A (en)
CN (1) CN1251525A (en)
AR (1) AR011094A1 (en)
AU (1) AU6094098A (en)
BR (1) BR9807523A (en)
CA (1) CA2278773A1 (en)
DE (1) DE19703131A1 (en)
ID (1) ID22414A (en)
IL (1) IL130877A0 (en)
NO (1) NO993670L (en)
PL (1) PL334770A1 (en)
SK (1) SK99899A3 (en)
WO (1) WO1998032442A1 (en)
ZA (1) ZA98679B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
CA2374198A1 (en) * 1998-05-29 1999-12-02 Maki Arai Combination therapy for treatment of fiv infection
GB9821000D0 (en) * 1998-09-28 1998-11-18 Glaxo Group Ltd Antiviral combinations
AU6329599A (en) * 1998-09-28 2000-04-17 Glaxo Group Limited Antiviral combinations comprising (s)-2-ethyl -7-fluoro -3-oxo-3, 4-dihydro -2h-quinoxaline -1-carboxylic acid isopropyl ester
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
SE9902987D0 (en) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CO5300399A1 (en) 2000-02-25 2003-07-31 Astrazeneca Ab HETEROCICLIOCS CONTAINING NITROGEN, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US7005439B2 (en) 2000-06-20 2006-02-28 Astrazeneca Ab Compounds
AR028948A1 (en) 2000-06-20 2003-05-28 Astrazeneca Ab NEW COMPOUNDS
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
AR035230A1 (en) 2001-03-19 2004-05-05 Astrazeneca Ab BENCIMIDAZOL COMPOUNDS, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION, AND USES OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0101038D0 (en) 2001-03-23 2001-03-23 Astrazeneca Ab Novel compounds
SE0103818D0 (en) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (en) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
EP1962841A1 (en) * 2005-12-15 2008-09-03 Bayer HealthCare AG Diaryl urea for treating virus infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE205837T1 (en) * 1991-04-15 2001-10-15 Aventis Pharma Gmbh CHINOXALINES, PROCESS FOR THEIR PRODUCTION AND THEIR USE
DE4342024A1 (en) * 1993-12-09 1995-06-14 Hoechst Ag Combination preparations containing a quinoxaline and a nucleoside
DE19506742A1 (en) * 1995-02-27 1996-08-29 Bayer Ag Use of quinoxalines in combination with protease inhibitors as medicaments for the treatment of AIDS and / or HIV infections

Also Published As

Publication number Publication date
ZA98679B (en) 1998-08-05
KR20000070543A (en) 2000-11-25
CA2278773A1 (en) 1998-07-30
SK99899A3 (en) 2000-03-13
AR011094A1 (en) 2000-08-02
DE19703131A1 (en) 1998-07-30
CN1251525A (en) 2000-04-26
JP2001511124A (en) 2001-08-07
IL130877A0 (en) 2001-01-28
EP0977570A1 (en) 2000-02-09
WO1998032442A1 (en) 1998-07-30
AU6094098A (en) 1998-08-18
BR9807523A (en) 2000-03-21
ID22414A (en) 1999-10-14
NO993670L (en) 1999-09-10
PL334770A1 (en) 2000-03-13

Similar Documents

Publication Publication Date Title
NO993670D0 (en) Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as a drug for the treatment of AIDS
FI955315A (en) Inhibitors of HIV protease, useful in the treatment of AIDS
BR9712544B1 (en) SERINE PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITION UNDERSTANDING THE SAME AND ITS USES
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
NO20024528L (en) Protease inhibitor, pharmaceutical composition and use of the compound
NO992492D0 (en) Benzamidoaldehydes and their use as cysteine protease inhibitors
EE200200214A (en) Use of dipyridamole or mopidamol in the manufacture of a medicament for the prevention and treatment of fibrin dependent microcirculation disorders
EE05056B1 (en) Use of IL-18 inhibitors in the manufacture of a medicament for the treatment and / or prevention of atherosclerosis
IS5504A (en) Composition active in the treatment of impotence
DK0929516T3 (en) Benzamidine derivatives and their use as drugs with LTB4 antagonistic effect
NO960775D0 (en) Use of quinoxalins in combination with protease inhibitors as a drug for the treatment of AIDS and / or HIV infections
EE04055B1 (en) Compounds and compositions for the treatment of diseases associated with serine protease activity, in particular tryptase activity, and their use
IS6033A (en) Aminotransferase-dependent amino acid-branched chain inhibitors and their use in the treatment of diabetic retinopathy
IS5990A (en) New amidine benzylamine derivatives and their use as thrombin inhibitors
DE69941825D1 (en) DRUG-CONTAINING RUBBER, THE METHOD OF MANUFACTURING THE SAME AND THE TABLET OBTAINED THEREWITH
FI935780A (en) HIV protease inhibitors useful in the treatment of AIDS
AU9624398A (en) Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors
NO20001717D0 (en) Serotonin-containing formulation for oral administration and use of the same
NO20004920D0 (en) Use of protease inhibitors for the treatment of skin damage
TR200002939T2 (en) Paroxetine maleate
AU7688998A (en) Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
NO990949D0 (en) Use of PKC inhibitors in the manufacture of a medicament for the treatment of AIDS
DK1032559T3 (en) Aminoalkylphenol derivatives for the treatment of depression and memory failure
IL141056A0 (en) Protease inhibitors for use in the treatment of psoriasis
DE69912315D1 (en) ((AMINOIMINOMETHYL) AMINO) ALKANECARBOXAMIDES AND THEIR THERAPEUTIC USE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application